SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (333)1/20/1999 12:26:00 PM
From: aknahow  Read Replies (1) | Respond to of 712
 
Don't get CNBC so I don't know if it is Eisinger you are referring to. Thought it was J. Cramer from the TSC that makes the appearances. Let me know as I would be interested in hearing what Eisinger is saying.

Monsantos decision to drop its oral antiplatlet drugs seems to have impacted Cor as it is great that some competition is removed but not clear that Cor will not have similar problems with its' own oral drug.